GEN Exclusives

More »

Feature Articles

More »
Mar 15, 2009 (Vol. 29, No. 6)

miRNA Profiling Opens Doors for New Drugs

Researchers Are Working to Understand Its Role and the Cellular Pathways It Affects

  • miRNAs in Lupus

    Researchers at the University of Pennsylvania School of Medicine are investigating the role of miRNAs in the pathogenesis of systemic lupus erythematosus (SLE). “We are currently profiling miRNAs in T and B cells deriving from the lupus-prone tri-congenic mouse model, B6.Sle123,” says Marianthi Kiriakidou, M.D., associate professor.

    The miRNA from these mice is compared to that of a control mouse strain. Since the disease in SLE mice evolves as they age, Dr. Kiriakidou says they also study and compare the miRNA signature among younger and older SLE mice. So far, several miRNAs have been identified that are regulated in SLE mice.

    Lupus is a systemic autoimmune disease that can potentially affect every organ. “At the molecular level, our understanding of the mechanisms affected in SLE is limited. Changes in the expression of miRNAs, a defected link in the molecular chain that each of these pathways represents, will serve as a marker to trace these pathways, offering new insights into the pathogenesis of lupus.”

    In order to further understand what’s occurring on the molecular level, Dr. Kiriakidou says her lab is also focusing on the biology of the miRNAs and proteins of the Argonaute family that associate with miRNAs in forming microRNPs—the functional units in the miRNA pathway. “Proteins that form the microRNPs are the effectors of the microRNA-mediated gene silencing,” she explains. Ongoing studies include in vitro studies using recombinant mouse Ago2, with the goal to characterize the RNA binding and catalytic and translational repressive activity of mammalian Ago2. “Our goal is to probe the function and contribution of miRNAs in an autoimmune disease model,” Dr. Kiriakidou summarizes.

    Scientists in the miRNA field believe these molecules hold great promise, as more studies confirm miRNA profiling holds potential to distinguish cancer from normal tissues. Once thought as useless noncoding RNAs, miRNAs are advancing to perhaps revolutionize disease therapeutics and diagnostics. These may well turn out to be the next magic bullet in medicine’s arsenal.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »